Literature DB >> 19710558

Lymphocytic leiomyositis and myenteric ganglionitis are intrinsic features of cystic fibrosis: studies in distal intestinal obstruction syndrome and meconium ileus.

Virpi V Smith1, Michela G Schäppi, W Michael Bisset, Fevronia Kiparissi, Adam Jaffe, Peter J Milla, Keith J Lindley.   

Abstract

BACKGROUND: Cystic fibrosis (CF) is a multisystem disorder intrinsically associated with inflammation of mucosal surfaces. Because inflammation can result in enteric neuromuscular dysfunction we hypothesized that terminal ileitis in patients with CF may predispose to distal ileal obstruction syndrome (DIOS). METHODS AND PATIENTS: Full-thickness terminal ileal tissues from 6 children with CF and severe DIOS, 6 infants with complicated meconium ileus (MI), and 6 children with non-CF intestinal atresia were studied.
RESULTS: Lymphocyte-predominant mucosal and transmural ileal inflammation was present in 6 of 6 patients with DIOS. Lymphocytic ganglionitis was present in 4 of 6 although numbers of myenteric neurons were not decreased (5/5). Myocyte proteins were preserved (6/6). Mild submucosal fibrosis was common in DIOS (5/6) and transformation of submucosal fibroblasts to a myofibroblastic phenotype was noted in 4 of 6. Inflammatory changes were distinct from those described in fibrosing colonopathy. Antroduodenal manometry in an individual who had experienced MI/DIOS was consistent with a neuropathic pseudo-obstructive process. Submucosal or transmural lymphocyte predominant inflammation was also present in 6 of 6 infants with complicated MI, which, when coupled with submucosal myofibroblast proliferation (5/6), appeared highly predictive of CF rather than non-CF atresia. Histological findings at birth were similar, although milder, than those seen in DIOS, suggesting that these changes are a primary abnormality in CF.
CONCLUSIONS: Submucosal or transmural inflammation of the ileum is common in newborns with CF and MI and older children with DIOS. Severe recurrent DIOS should be investigated with seromuscular and mucosal biopsy of the ileum to seek a transmural ileitis potentially amenable to anti-inflammatory therapies.

Entities:  

Mesh:

Year:  2009        PMID: 19710558     DOI: 10.1097/MPG.0b013e318186d35a

Source DB:  PubMed          Journal:  J Pediatr Gastroenterol Nutr        ISSN: 0277-2116            Impact factor:   2.839


  8 in total

Review 1.  The Enigmatic Gut in Cystic Fibrosis: Linking Inflammation, Dysbiosis, and the Increased Risk of Malignancy.

Authors:  Millie Garg; Chee Y Ooi
Journal:  Curr Gastroenterol Rep       Date:  2017-02

2.  Azathioprine in the management of enteropathy in cystic fibrosis.

Authors:  Hui-Leng Tan; Neil Shah; Ranjan Suri
Journal:  J R Soc Med       Date:  2011-07       Impact factor: 5.344

Review 3.  Cystic fibrosis from the gastroenterologist's perspective.

Authors:  Chee Y Ooi; Peter R Durie
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2016-01-21       Impact factor: 46.802

Review 4.  Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation.

Authors:  Hubert P J van der Doef; Freddy T M Kokke; Cornelis K van der Ent; Roderick H J Houwen
Journal:  Curr Gastroenterol Rep       Date:  2011-06

5.  Expression of Cystic Fibrosis Transmembrane Conductance Regulator in Ganglia of Human Gastrointestinal Tract.

Authors:  Ruiqi Xue; Huan Gu; Yamei Qiu; Yong Guo; Christine Korteweg; Jin Huang; Jiang Gu
Journal:  Sci Rep       Date:  2016-08-05       Impact factor: 4.379

6.  The management of adult patients with severe chronic small intestinal dysmotility.

Authors:  Jeremy M D Nightingale; Peter Paine; John McLaughlin; Anton Emmanuel; Joanne E Martin; Simon Lal
Journal:  Gut       Date:  2020-08-21       Impact factor: 23.059

7.  Proximal intestinal obstruction syndrome (PIOS) in a patient with cystic fibrosis: A case report.

Authors:  Carlos Antonio Morales Morales; Mauricio Gonzalez-Urquijo; Luis Fernando Morales Flores; Enrique Quevedo-Fernandez; Eduardo Alberto Guzmán Huerta; Martín Mauricio Virgilio Hernández-Torre
Journal:  Ann Med Surg (Lond)       Date:  2020-12-03

8.  CFTR Knockdown induces proinflammatory changes in intestinal epithelial cells.

Authors:  Karoline St-Martin Crites; Geneviève Morin; Valérie Orlando; Natacha Patey; Catherine Cantin; Judith Martel; Emmanuelle Brochiero; Geneviève Mailhot
Journal:  J Inflamm (Lond)       Date:  2015-11-07       Impact factor: 4.981

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.